SEC Company Response from Adicet Bio, Inc. (ACET) (CIK 0001720580) (ACET) — Jan 23, 2018
Adicet Bio, Inc. (ACET) (CIK 0001720580)
Date: Jan. 23, 2018 · CIK: 0001720580 · Accession: 0001193125-18-017394
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-222373
Letter
Re: resTORbio, Inc. (the “Company”)
January 23, 2018
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Irene Paik
Registration Statement on Form S-1
File No. 333-222373
Acceleration Request
Requested Date: January 25, 2018
Requested Time: 4:00 p.m. Eastern Standard Time
Ladies and Gentlemen:
As representatives of the several underwriters of the Company’s proposed initial public offering, we hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 4:00 p.m., Eastern Standard Time, on January 25, 2018, or as soon thereafter as is practicable.
Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus, dated January 16, 2018, through the date hereof:
Preliminary Prospectus dated January 16, 2018:
1,290 copies to prospective underwriters, institutional investors, dealers and others
The undersigned advises that it has complied and will continue to comply, and that it has been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Remainder of Page Intentionally Left Blank]
Very truly yours,
As representatives of the several underwriters
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
January 23, 2018
U.S. Securities and Exchange Commission
Division of Corporation
Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Irene Paik
Re:
resTORbio, Inc. (the “Company”)
Registration Statement on Form S-1
File No. 333-222373
Acceleration Request
Requested Date: January 25, 2018
Requested Time: 4:00 p.m. Eastern Standard Time
Ladies and Gentlemen:
As representatives of the several underwriters of the Company’s proposed initial public offering, we hereby join the Company’s
request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 4:00 p.m., Eastern Standard Time, on January 25, 2018, or as soon
thereafter as is practicable.
Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under
the Securities Act of 1933, as amended, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus, dated January 16, 2018, through the date hereof:
Preliminary Prospectus dated January 16, 2018:
1,290 copies to prospective underwriters, institutional investors, dealers and others
The undersigned advises that it has complied and will continue to comply, and that it has been informed by the participating underwriters and
dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Remainder of Page Intentionally Left Blank]
Very truly yours,
As representatives of the several underwriters
MERRILL
LYNCH, PIERCE, FENNER & SMITH
INCORPORATED
By:
/s/ Anurag Jindal
Name: Anurag Jindal
Title: Managing
Director
LEERINK PARTNERS LLC
By:
/s/ John I. Fitzgerald
Name: John I. Fitzgerald
Title: Managing
Director
[Signature Page to Underwriter Acceleration Request]